Taysha Gene Therapies, Inc. (TSHA)

Taysha Gene Therapies Stock Forecast

Stock Price Forecast

According to 7 professional analysts, the 12-month price target for Taysha Gene Therapies stock ranges from a low of $5.00 to a high of $8.00. The average analyst price target of $6.43 forecasts a 153.65% increase in the stock price over the next year.

Price Target: $6.43 (+153.65%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$6.43	$7.00	$8.00
Change	+97.24%	+153.65%	+176.13%	+215.58%

Analyst Ratings

The average analyst rating for Taysha Gene Therapies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	4	4	4	4	4	3
Buy	4	4	4	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	8	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Silvan Tuerkcan JMP Securities	JMP Securities	Buy Reiterates $5	Buy	Reiterates	$5	+97.24%	Apr 28, 2025
Kristen Kluska Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates $7	Buy	Reiterates	$7	+176.13%	Apr 28, 2025
Gil Blum Needham	Needham	Strong Buy Reiterates $6	Strong Buy	Reiterates	$6	+136.69%	Apr 10, 2025
Gil Blum Needham	Needham	Strong Buy Reiterates $6	Strong Buy	Reiterates	$6	+136.69%	Feb 27, 2025
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $7	Strong Buy	Maintains	$7	+176.13%	Feb 26, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

6.85M

Decreased by -17.86%

from 8.33M

Revenue Next Year

4.52M

Decreased by -33.94%

from 6.85M

EPS This Year

-0.38

from -0.36

EPS Next Year

-0.45

from -0.38

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	2.50M	15.45M	8.33M	6.85M	4.52M	43.78M
Revenue Growth	-	-	-	517.55%	-46.07%	-17.86%	-33.94%	868.18%
EPS	-3.40	-4.64	-3.78	-0.96	-0.36	-0.38	-0.45	-0.00
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	13	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	15.8M	11.4M	85.1M
Avg	6.8M	4.5M	43.8M
Low	n/a	n/a	7.9M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	89.0%	67.2%	1,781.0%
Avg	-17.9%	-33.9%	868.2%
Low	-	-	75.1%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.33	-0.34	1.42
Avg	-0.38	-0.45	-0.00
Low	-0.42	-0.73	-0.41

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.